slotkoers
Korea S.E.
00:00:00 31-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
7.520
KRW
|
+0,67%
|
|
-0,27%
|
-20,09%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
113.958
|
123.186
|
148.969
|
122.613
|
104.448
|
106.948
|
Bedrijfswaarde
1 |
79.288
|
72.802
|
119.504
|
95.344
|
86.011
|
89.181
|
K/w-verhouding
|
8,71
x
|
48,6
x
|
-113
x
|
31,1
x
|
15,2
x
|
82,9
x
|
Dividendrendement
|
2,22%
|
2,05%
|
1,69%
|
2,06%
|
2,39%
|
2,34%
|
Marktkapitalisatie/omzet
|
0,61
x
|
0,79
x
|
1,04
x
|
0,75
x
|
0,51
x
|
0,46
x
|
Bedrijfswaarde/omzet
|
0,43
x
|
0,47
x
|
0,83
x
|
0,58
x
|
0,42
x
|
0,38
x
|
Bedrijfswaarde/EBITDA
|
4,26
x
|
11,6
x
|
25,8
x
|
27,9
x
|
6,01
x
|
8,84
x
|
Bedrijfswaarde/FCF
|
-15
x
|
4,16
x
|
-9,75
x
|
-96,5
x
|
49,7
x
|
19,9
x
|
FCF Yield
|
-6,65%
|
24,1%
|
-10,3%
|
-1,04%
|
2,01%
|
5,04%
|
Price to Book
|
0,77
x
|
0,83
x
|
1,03
x
|
0,8
x
|
0,67
x
|
0,7
x
|
Aantal aandelen (in duizenden)
|
11.511
|
11.459
|
11.459
|
11.459
|
11.365
|
11.365
|
Referentieprijs
2 |
9.900
|
10.750
|
13.000
|
10.700
|
9.190
|
9.410
|
Datum van publicatie
|
21-03-19
|
12-03-20
|
17-03-21
|
21-03-22
|
22-03-23
|
20-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
185.746
|
155.852
|
143.364
|
163.534
|
205.389
|
233.676
|
EBITDA
1 |
18.629
|
6.272
|
4.634
|
3.423
|
14.311
|
10.084
|
Bedrijfsresultaat (EBIT)
1 |
15.366
|
2.418
|
-49,1
|
-1.084
|
9.381
|
5.061
|
Operationele Marge
|
8,27%
|
1,55%
|
-0,03%
|
-0,66%
|
4,57%
|
2,17%
|
Resultaat voor belastingen (EBT)
1 |
16.366
|
2.176
|
778,1
|
3.805
|
7.375
|
4.267
|
Nettowinst (verlies)
1 |
13.220
|
2.536
|
-1.315
|
3.939
|
6.875
|
1.290
|
Nettomarge
|
7,12%
|
1,63%
|
-0,92%
|
2,41%
|
3,35%
|
0,55%
|
WPA
2 |
1.136
|
221,3
|
-114,8
|
343,9
|
604,0
|
113,5
|
Free Cash Flow
1 |
-5.274
|
17.516
|
-12.257
|
-988,1
|
1.732
|
4.491
|
FCF-marge
|
-2,84%
|
11,24%
|
-8,55%
|
-0,6%
|
0,84%
|
1,92%
|
Kasstroomconversie (ebitda)
|
-
|
279,29%
|
-
|
-
|
12,1%
|
44,54%
|
Kasstroomconversie (nettowinst)
|
-
|
690,79%
|
-
|
-
|
25,19%
|
348,14%
|
Dividend per aandeel
2 |
220,0
|
220,0
|
220,0
|
220,0
|
220,0
|
220,0
|
Datum van publicatie
|
21-03-19
|
12-03-20
|
17-03-21
|
21-03-22
|
22-03-23
|
20-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
34.670
|
50.384
|
29.465
|
27.269
|
18.437
|
17.767
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-5.274
|
17.516
|
-12.257
|
-988
|
1.732
|
4.491
|
ROE (netto-inkomsten/eigen vermogen)
|
9,26%
|
1,45%
|
-0,95%
|
2,52%
|
4,47%
|
0,65%
|
ROA (netto-inkomsten/totale activa)
|
4,56%
|
0,7%
|
-0,01%
|
-0,32%
|
2,64%
|
1,37%
|
Totale activa
1 |
289.753
|
361.508
|
9.009.430
|
-1.226.025
|
260.264
|
94.314
|
Nettoactief per aandeel
2 |
12.808
|
12.937
|
12.575
|
13.441
|
13.683
|
13.382
|
Cashflow per aandeel
2 |
1.874
|
1.985
|
1.114
|
1.196
|
1.610
|
2.551
|
Capex
1 |
2.914
|
3.738
|
24.119
|
4.035
|
2.931
|
5.474
|
Capex/omzet
|
1,57%
|
2,4%
|
16,82%
|
2,47%
|
1,43%
|
2,34%
|
Datum van publicatie
|
21-03-19
|
12-03-20
|
17-03-21
|
21-03-22
|
22-03-23
|
20-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -20,09% | 61,8 mln. | | +15,37% | 41,97 mld. | | +22,56% | 22,34 mld. | | +15,48% | 15,25 mld. | | +16,53% | 14 mld. | | +49,78% | 12,06 mld. | | -10,77% | 6,8 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +14,18% | 5,49 mld. |
Generieke geneesmiddelen
|